NCT03126916 2026-02-27
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Phase 3 Recruiting
Children's Oncology Group
Children's Oncology Group
Italian Sarcoma Group
Children's Oncology Group
Canadian Cancer Trials Group
European Myeloma Network B.V.
SWOG Cancer Research Network
Children's Oncology Group
Grupo de Estudos Multicentricos em Onco-Hematologia